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In cytokinesis with chromatin bridges, cells delay abscission and retain actin patches at the intercellular canal to prevent 
chromosome breakage. In this study, we show that inhibition of Src, a protein-tyrosine kinase that regulates actin dynamics, 
or Chk1 kinase correlates with chromatin breakage and impaired formation of actin patches but not with abscission in 
the presence of chromatin bridges. Chk1 is required for optimal localization and complete activation of Src. Furthermore, 
Chk1 phosphorylates human Src at serine 51, and phosphorylated Src localizes to actin patches, the cell membrane, or the 
nucleus. Nonphosphorylatable mutation of S51 to alanine reduces Src catalytic activity and impairs formation of actin 
patches, whereas expression of a phosphomimicking Src-S51D protein rescues actin patches and prevents chromatin 
breakage in Chk1-deficient cells. We propose that Chk1 phosphorylates Src-S51 to fully induce Src kinase activity and that 
phosphorylated Src promotes formation of actin patches and stabilizes chromatin bridges. These results identify proteins 
that regulate formation of actin patches in cytokinesis.
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Introduction
Chromatin bridges are strands of incompletely segregated chro-
matin that connect anaphase poles or daughter nuclei and have 
been linked to tumorigenesis (Hoffelder et al., 2004; Ganem and 
Pellman, 2012). In the presence of chromatin bridges, eukary-
otic cells delay abscission, the final cut of the narrow cytoplasmic 
canal that connects the daughter cells, to prevent tetraploidiza-
tion by regression of the cleavage furrow or chromatin breakage 
(Steigemann et al., 2009; Nähse et al., 2017). In mammals, this 
abscission delay is called the abscission checkpoint and relies 
on the Aurora B protein kinase (Steigemann et al., 2009; Nähse 
et al., 2017). Activated Aurora B phosphorylates the endosomal 
sorting complex required for transport-III (ESC RT-III) subunit 
charged multivesicular body protein 4C (Chmp4c; Capalbo et al., 
2012; Carlton et al., 2012; Petsalaki and Zachos, 2016). In turn, 
phosphorylated Chmp4c can cooperate with several proteins to 
inhibit the ATPase Vps4 at the midbody and prevent its activity 
on ESC RT-III filaments in order to inhibit abscission (Morita et 
al., 2007; Thoresen et al., 2014; Caballe et al., 2015). Furthermore, 
cells with chromatin bridges form and retain actin-rich struc-
tures called actin patches at the base of the chromatin bridge 
(Chen and Doxsey, 2009; Steigemann et al., 2009). It is suggested 
that actin patches stabilize the intercellular canal until the DNA 
bridge is resolved; however, how actin patches are formed has not 
been previously reported.
Src is a nonreceptor tyrosine kinase that is involved in a 
diverse spectrum of biological activities including cell prolifera-
tion, adhesion, spreading, and migration (Playford and Schaller, 
2004). Src is located at the plasma membrane and is also found at 
late endosomes, the Golgi apparatus, and the nucleus (Takahashi 
et al., 2009). Src family kinases share a conserved domain struc-
ture consisting of an amino-terminal membrane-binding SH4 
domain with a myristoylation sequence, followed by a “Unique” 
region that is divergent among family members (amino acids 
20–85 of human Src), consecutive Src homology 3 (SH3) and 
SH2 domains, and a kinase domain that is followed by a short 
C-terminal tail (Maffei et al., 2015; Roskoski, 2015). The C-ter-
minal tail contains an autoinhibitory phosphorylation site (tyro-
sine 530 [Y530] in human Src), and phosphorylation at this site 
promotes assembly of the SH2, SH3, and kinase domains into an 
autoinhibited “closed” conformation (Xu et al., 1997; Brábek et 
al., 2002). Displacement of the SH3- and SH2-mediated intra-
molecular interactions by Src binding to downstream substrates 
or higher-affinity ligands allows dephosphorylation of Src-
Y530, followed by autophosphorylation of tyrosine 419 (Y419) 
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inside the human Src catalytic loop, and leading to conversion 
of the enzyme into an active “open” form (Bernadó et al., 2008; 
Roskoski, 2015). In addition, the Unique domain of Src contains 
phosphorylation residues that activate Src by promoting dephos-
phorylation of the autoinhibitory site (Shenoy et al., 1992; Stover 
et al., 1994) or regulate Src binding to lipids (Pérez et al., 2013; 
Amata et al., 2014).
Activating mutations in cellular Src or infection with the 
Src encoding Rous sarcoma virus can cause oncogenic trans-
formation that is accompanied by dramatic changes in the actin 
cytoskeleton (Frame, 2002). Src binds to FAK at focal adhe-
sions and phosphorylates FAK at various residues including 
tyrosine 925 (Y925) to activate FAK or create binding sites for 
adaptor proteins (Brunton et al., 2005; Mitra et al., 2005). In 
turn, the FAK–Src signaling complex promotes changes in actin 
cytoskeleton and regulates focal adhesion turnover (Goldberg 
et al., 2003; Brown et al., 2005; Mitra et al., 2005). Src phos-
phorylates cortactin to enhance actin nucleation and binds 
to formins to induce formation of stress fibers (Tominaga 
et al., 2000; Tehrani et al., 2007). In addition, Src signaling 
is involved in the completion of cytokinesis (Kasahara et al., 
2007a; Kamranvar et al., 2016).
Chk1 kinase was first identified to regulate the DNA damage 
response (Smith et al., 2010); however, it is also required for 
proper mitotic cell division (Zachos et al., 2007; Peddibhotla et 
al., 2009). Chk1 phosphorylates the mitotic kinase Aurora B in 
prometaphase and metaphase to induce Aurora B catalytic activ-
ity and promote correction of misattached kinetochore–micro-
tubules (Petsalaki et al., 2011; Petsalaki and Zachos, 2013). Also, 
Chk1 is required for successful chromosome segregation and 
cytokinesis and for an abscission delay in response to replica-
tion stress (Peddibhotla et al., 2009; Petsalaki et al., 2014; Mackay 
and Ullman, 2015). In this study, we show that Chk1 phosphor-
ylates human Src at the newly identified site serine 51 to fully 
induce Src kinase activity. We also show that phosphorylated Src 
promotes formation of actin patches and prevents chromosome 
breakage in cytokinesis with chromatin bridges.
Results
Src and Chk1 prevent chromatin breakage in cytokinesis
Because Src and Chk1 are involved in completion of cytokinesis 
(Kasahara et al., 2007a; Mackay and Ullman, 2015), we investi-
gated their potential role in cytokinesis with chromatin bridges. 
Confocal microscopy analysis of fixed human colon carcinoma 
BE cells in telophase showed that 30–34% cells treated with PP2, 
a catalytic inhibitor of Src family tyrosine kinases, or depleted 
of Chk1 or Src by, respectively, Chk1 siRNA (siChk1) or Src siRNA 
(siSrc), exhibited broken DNA bridges compared with ∼5% con-
trol (Fig. 1, A and B; and Fig. S1, A and B). Treatment with PP2 did 
not exacerbate chromatin breakage in Chk1-depleted cells, sug-
gesting that Chk1 and Src prevent chromatin breakage by acting 
through the same mechanism (Fig. 1 B). Also, Chk1 or Src inhi-
bition increased the frequency of chromatin bridges that were 
positive for phospho-Ser139 histone H2A.X (γ-H2AX) staining, 
which is a marker for double-strand DNA breaks (Fig. 1, C and D; 
Janssen et al., 2011).
To further investigate the role of Chk1 and Src in chroma-
tin breakage, HeLa cells expressing the inner nuclear envelope 
marker LAP2b fused to RFP (LAP2b-RFP) and displaying LAP2b-
RFP bridges in cytokinesis were monitored for up to 180 min by 
time-lapse microscopy. LAP2b-RFP localizes around chroma-
tin from late anaphase and correlates with chromatin bridges 
(Steigemann et al., 2009). We found that 15/15 control cells 
exhibiting intercellular canals with LAP2b-RFP bridges sus-
tained those canals for the duration of the experiment (Fig. 1 E, 
Fig. S1 C, and Video 1). In contrast, 11/13 cells treated with PP2 
exhibited breakage of intercellular canals containing LAP2b-RFP 
bridges after 47 ± 14 min (n = 11; Fig. 1 E, Fig. S1 C, and Video 2). 
Furthermore, 11/13 cells treated with the selective Chk1 inhib-
itor UCN-01 displaying intercellular canals with LAP2b-RFP 
bridges exhibited breakage of those canals after 52 ± 15 min (n = 
11; Fig. 1 E, Fig. S1 C, and Video 3). Confocal microscopy analysis 
of fixed HeLa LAP2b-RFP cells also showed that Chk1- or Src- 
deficient cells exhibited increased frequency of broken LAP2b-
RFP bridges compared with controls (Fig.  1, F and G). These 
results suggest that Chk1 and Src prevent chromatin breakage in 
cytokinesis with chromatin bridges.
Fragmented chromatin bridges can lead to the formation of 
micronuclei and accumulation of DNA damage (Hoffelder et al., 
2004). Depletion of Src or Chk1 increased the frequency of BE 
cells exhibiting micronuclei that were devoid of nuclear lamin 
B2 compared with controls (Fig. 2, A and C), which is consistent 
with these micronuclei being bridge-derived (Utani et al., 2010). 
Furthermore, Src- or Chk1-deficient cells exhibited increased 
frequency of micronuclei that were positive for γ-H2AX stain-
ing compared with controls (Fig.  2, B and C). These results 
suggest that Src and Chk1 are required to prevent formation of 
micronuclei and generation of DNA damage in cytokinesis with 
chromatin bridges.
Src and Chk1 are required for actin patch formation in 
cytokinesis with chromatin bridges
Control cells with chromatin bridges exhibited actin patches, 
i.e., regions of relatively high intensity F-actin staining, at both 
sides of the DNA bridge (Fig. 2 D). However, Src- or Chk1-deficient 
cells exhibited reduced actin patches, and this was not a result of 
diminished total levels of actin compared with controls (Fig. 2, 
D–F; and Fig. S1 D). Control cells with relatively strong or weak 
DNA bridge labeling (i.e., with DNA bridge fluorescence above 
or below, respectively, the control mean) exhibited similar actin 
patches (Fig. 3, A and B). Also, Chk1- or Src-depleted cells exhib-
ited reduced actin patches compared with controls regardless of 
the intensity of the DNA bridge signal (relatively strong versus 
weak signal; Fig. 3, A and B; and Fig. S1 E), suggesting that the 
amount of DNA inside the intercellular canal does not asso-
ciate with the intensity of actin patches. Actin patches were 
also diminished in Src- or Chk1-deficient cells with intact DNA 
bridges, suggesting that impaired actin patches were not a con-
sequence of chromatin breakage (Fig. S1, F–H). Expression of WT 
GFP-Src that is resistant to degradation by a second siSrc (siSrc-
2), or GFP-Chk1, resistant to degradation by siChk1-2, reduced 
chromatin breakage and rescued formation of actin patches 
after depletion of the endogenous Src or Chk1 compared with 
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Figure 1. Src or Chk1-inhibition correlates with chromatin breakage. (A) DNA bridges in cells transfected with negative siRNA (control), siSrc, or siChk1, or 
treated with PP2 for 5 h. (B) Percentage of DNA bridges that appear broken. (C and D) γ-H2AX staining (C) and frequency of telophase cells with DNA bridges 
exhibiting γ-H2AX staining (D). Arrowheads indicate γ-H2AX foci on DNA bridges. (E and F) HeLa cells expressing LAP2b-RFP were analyzed by phase-contrast 
live-cell imaging (E) or by fluorescence microscopy of fixed samples (F). Time is from the detection of the intercellular canals containing LAP2b-RFP bridges. 
Intact intercellular canals are indicated by solid arrows, and broken canals are indicated by dotted arrows. Related to Videos 1, 2, and 3. (G) Percentage of 
LAP2b-RFP–positive bridges that appear broken. Broken DNA or LAP2b bridges are indicated by dotted arrows. Error bars show the SD from the mean from 
three independent experiments. A minimum of 50 fixed cells with chromatin bridges was analyzed per experiment. ***, P < 0.001 compared with the control. 
Statistically significant differences were determined by ANO VA and Student’s t test. Bars, 5 µm.
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Figure 2. Inhibition of Src or Chk1 diminishes formation of actin patches. (A and B) Cells were transfected with negative siRNA (control), siSrc, or siChk1. 
Lamin B–negative (A) or γ-H2AX–positive micronuclei (B) are indicated by arrowheads. (C) Frequency of cells exhibiting lamin B-negative or γ-H2AX–positive 
micronuclei. Error bars show the SD from the mean from three independent experiments. A minimum of 150 cells was analyzed per experiment. (D) Cells were 
transfected as in A or treated with PP2 for 5 h. Broken DNA bridges are indicated by dotted arrows, and the bases of the intercellular canals are indicated by 
solid arrows. Relative actin patch intensity values are shown. Insets show 3× magnification of the canals bases. Bars, 5 µm. (E) Actin patches intensity. Relative 
green fluorescence intensity from D is shown, and values in control were set to 1. Error bars show the SD from the mean. n = 30 cells from three independent 
experiments. ***, P < 0.001 compared with the control. Statistically significant differences were determined by ANO VA and Student’s t test. (F) Western blot 
analysis of total α-tubulin and actin.
Dandoulaki et al. 
Src activation by Chk1 prevents chromatin breakage
Journal of Cell Biology
https://doi.org/10.1083/jcb.201802102
3075
cells expressing GFP alone (Fig. 3, C–F; and Fig. S1, I and J). These 
results show that Src and Chk1 are required for stable chromatin 
bridges and formation of actin patches in cytokinesis.
Chromatin breakage in Src- or Chk1-deficient cells is not 
caused by abscission
Approximately 70% of Src- or Chk1-depleted cells with broken 
DNA bridges exhibited intact intercellular canals as evidenced 
by staining with FM 1-43FX, a fluorescence lipophilic dye that 
labels membranes (Fig. 4, A and B; Fuenzalida et al., 2011), sug-
gesting that chromatin breakage in Src- or Chk1-deficient cells 
does not correlate with abscission. For comparison, 45/45 cells 
treated with the Cdc-like kinase inhibitor TG003 that inhibits the 
abscission checkpoint (Petsalaki and Zachos, 2016) with broken 
DNA bridges exhibited broken intercellular canals, indicating 
that TG003-treated cells had finished abscission (Fig. 4, A and B). 
Also for comparison, 21/21 control cells with intact DNA bridges 
exhibited intact intercellular canals (Fig. 4 C). To further inves-
tigate the mechanism of chromatin breakage, cells expressing 
mutant Vps4 protein fused to GFP in which Vps4-lysine 173 was 
changed to glutamine (GFP-Vps4-K173Q), to abrogate ATP bind-
ing to Vps4 and inhibit abscission (Morita et al., 2007; Petsalaki 
and Zachos, 2016), or GFP alone were examined. In cells depleted 
of Src or Chk1, expression of GFP–Vps4-K173Q did not prevent 
breakage of DNA bridges compared with cells expressing GFP 
(Fig. 4, D and E). For comparison, expression of GFP-Vps4-K173Q 
prevented chromatin breakage after treatment with TG003 or 
Aurora B depletion compared with cells expressing GFP only 
(Fig.  4, D and E; and Fig. S2 A), confirming that Vps4-K173Q 
inhibits abscission under the experimental conditions used in 
our study (Steigemann et al., 2009; Petsalaki and Zachos, 2016). 
These results show that chromatin breakage in Src- or Chk1-de-
ficient cells is not caused by abscission.
Chk1/Src and Aurora B cooperate to prevent 
chromatin breakage
Aurora B–deficient cells exhibit premature abscission 
(Steigemann et al., 2009), and Aurora B–deficient cells exhib-
ited increased frequency of broken chromatin bridges compared 
with controls despite having similar actin patches (Fig. 5, A–C). 
Simultaneous depletion of Chk1 or Src and Aurora B exacerbated 
chromatin breakage, and this correlated with reduced formation 
of actin patches and with increased frequency of cells with bro-
ken DNA bridges with an intact midbody (i.e., without abscis-
sion) compared with cells depleted of Aurora B only (Fig. 5, A–D). 
The remaining double-depleted cells with broken DNA bridges 
exhibited midbody remnants, i.e., midbodies severed from one 
daughter cell or completely disassembled midbody microtu-
bules (Fig. 5 A). Control cells with intact DNA bridges also exhib-
ited disassembled midbody microtubules (midbody remnants) 
despite the abscission delay (Fig. 5 A), in agreement with previ-
ous findings (Steigemann et al., 2009). The regulatory proteins 
Plk1, Mklp1, and Cep55 localize to the midbody in telophase or 
late cytokinesis in control cells (Mishima et al., 2002; Bastos and 
Barr, 2010), and Chk1 or Src depletion did not impair localiza-
tion of the above proteins to the midbody compared with con-
trols (Fig. 5, E and F; and Fig. S2, B–G). It was previously reported 
that pharmacological inhibition of Src resulted in reduced Plk1 
and increased Cep55 at the midbody in nontransformed cells 
(Kamranvar et al., 2016). Perhaps the difference between our 
results and those from Kamranvar et al. (2016) reflects physi-
ological differences between nontransformed and cancer cells. 
We propose that Chk1 and Src stabilize chromatin bridges by 
promoting formation of actin patches. These results also suggest 
that Chk1 and Src cooperate with the Aurora B–mediated abscis-
sion checkpoint to prevent chromatin breakage in cytokinesis 
with DNA bridges.
Src and Src-signaling proteins localize to actin patches
Proteins involved in actin remodeling can localize to actin struc-
tures. We found that the endogenous total Src, autophosphory-
lated Src-Y419 (active Src), and transfected WT GFP-Src localized 
to actin patches in control cells with chromatin bridges (Figs. 3 
D and 6, A and B). Phosphorylated FAK-Y925 (a phosphorylation 
substrate of Src; Brunton et al., 2005) and cortactin (Tehrani et 
al., 2007) also localized to actin patches in control cells (Fig. 6, C 
and E). These results indicate that actin patch formation is reg-
ulated by Src signaling. However, Chk1 was not enriched at actin 
patches in control cells with chromatin bridges (Fig. 6 F), sug-
gesting that Chk1 promotes formation of actin patches without 
stably localizing at the site.
Chk1 is required for optimal Src localization and kinase activity
Depletion of Chk1 or, for comparison, treatment with the Src 
family kinase inhibitor PP2 impaired localization of total Src 
and cortactin at the base of the intercellular canal and reduced 
phosphorylation of Src-Y419 and FAK-Y925 (which are markers 
of Src kinase activity) compared with control cells (Fig. 6, A–E), 
suggesting that Chk1 is required for optimal Src localization and 
kinase activity in cells with chromatin bridges. Chk1-deficient 
cells plated on fibronectin-coated dishes exhibited reduced lev-
els of autophosphorylated Src-Y419 and phosphorylated FAK-
Y925 by 40–60% compared with controls by Western blotting 
(Fig. 7, A and B). For comparison, Src inhibition by PP2 reduced 
phosphorylation of Src-Y419 and FAK-Y925 by ∼90% com-
pared with controls. However, Src or FAK protein levels per se 
were not affected by Chk1 depletion or PP2 treatment (Fig. 7, A 
and B). Furthermore, Chk1-deficient interphase cells without 
chromatin bridges exhibited reduced levels of phosphorylated 
Src-Y419 and phosphorylated FAK-Y925 and diminished local-
ization of total Src to membrane ruffles compared with controls 
(Fig. S3, A–E).
Inhibition of Src kinase activity reduces cell spreading and 
produces a more round cell morphology (Elias et al., 2010). Con-
trol or Chk1-depleted cells were trypsinized, allowed to attach 
on fibronectin-coated dishes in the absence or presence of PP2, 
and observed at various times by phase-contrast time-lapse 
microscopy. A relatively high percentage of Chk1-deficient or 
PP2-treated cells remained round and highly reflective, indicat-
ing that these cells were not able to spread properly, compared 
with flattened controls (Fig. 7, C and D). Also, Src kinase activity 
promotes migration of cells during wound healing (Di Florio et 
al., 2007). Depletion of Chk1 decreased wound closure of a mono-
layer of cells compared with controls (Fig. 7, E and F). Collectively, 
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Figure 3. Actin patches intensity is independent of the relative amount of DNA inside the intercellular canal. (A) Actin patches in cells transfected with 
negative siRNA (control), siSrc, or siChk1 exhibiting relatively strong or weak DNA staining inside the intercellular canal. The mean fluorescence intensity of 
control DNA bridges was set to 0.5, and relative DNA intensity values are indicated in the DNA insets. Relative DNA bridge staining >0.5 was taken as strong, 
and DNA bridge staining <0.5 was classified as weak. (B) Actin patches intensity. Relative green fluorescence intensity from A is shown, and values in strong 
DNA control were set to 1. Error bars show the SD from the mean. n = 20 cells from three independent experiments. (C and D) Cells expressing GFP, WT GFP-
Src resistant to degradation by Src-2 siRNA (siSrc-2), or GFP-Chk1 resistant to degradation by Chk1-2 siRNA (siChk1-2) were transfected with negative siRNA 
(control), siSrc-2, or siChk1-2. Broken DNA bridges are indicated by dotted arrows and the bases of the intercellular canals are indicated by solid arrows. Relative 
actin patch intensity values are shown. Insets show 1.6× magnification of the canals bases. Bars, 5 µm. (E) Broken bridges analysis. Error bars show the SD 
from the mean from three independent experiments. A minimum of 30 cells with chromatin bridges was analyzed per experiment. (F) Actin patches intensity. 
Relative red fluorescence intensity from C and D is shown, and values in GFP control were set to 1. Error bars show the SD from the mean. n = 30 cells from 
three independent experiments. ***, P < 0.001 compared with the control. Statistically significant differences were determined by ANO VA and Student’s t test.
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these results show that Chk1 is required for optimal Src kinase 
activity in interphase cells.
Chk1 phosphorylates Src serine 51 in vitro
To investigate whether Chk1 promotes Src kinase activity through 
phosphorylation, avian Src fused to GST (GST-avSrc) was incu-
bated with recombinant GST-Chk1 in kinase assays in vitro. In the 
presence of Chk1, GST-avSrc was radiolabeled at levels approxi-
mately sixfold higher compared with GST-avSrc alone, and this 
radiolabeling was reduced in the presence of the Chk1 inhibitor 
UCN-01, suggesting it was not a result of Src autophosphorylation 
(Figs. S3 F and S4, A and C). After labeling by Chk1, GST-avSrc 
was analyzed by liquid chromatography–mass spectrometry, 
and phosphorylation sites at avSrc-T46, S48, or S50, which were 
absent in GST-avSrc alone, were identified as Chk1 phosphoryla-
tion sites. Only monophosphorylated peptides were observed, and 
of these three sites, only the avSrc-S48 (Fig. S4 B) is conserved in 
the human protein and corresponds with human Src-S51. Non-
phosphorylatable mutation of S51 to alanine (S51A) markedly 
reduced phosphorylation of human GST-Src (1–256) by Chk1 com-
pared with the WT GST-Src (1–256), showing that Chk1 phosphor-
ylates human Src at the novel site S51 in vitro (Fig. 8 A). Serine 51 
is inside the Unique domain of Src and conforms to the minimum 
Chk1 consensus sequence R-x-x-S/T (Hutchins et al., 2000). Mul-
tiple sequence alignment demonstrated S51 is conserved in Src 
proteins from different species (Fig. 8 B).
Figure 4. Expression of dominant-negative 
Vps4-K173Q does not prevent chromatin 
breakage in Src or Chk1-deficient cells. (A 
and C) Examples of cells with DNA bridges 
exhibiting broken or intact intercellular canals 
after labeling with a lipophilic dye. Cells were 
transfected with negative siRNA (control), siSrc, 
or siChk1, or treated with TG003 for 5  h and 
stained with FM 1-43FX. (B) Frequency of cells 
with broken DNA bridges exhibiting intact inter-
cellular canals. Error bars show the SD from the 
mean from three independent experiments. 15 
cells with broken chromatin bridges were ana-
lyzed per experiment. (D) Cells expressing GFP 
or GFP–Vps4-K173Q were transfected with 
Aurora B siRNA (siAurora B; siAurB) or treated 
as in A–C. Broken DNA bridges or intercellular 
canals are indicated by dotted arrows. Bars, 5 
µm. (E) Percentage of DNA bridges that appear 
broken in GFP-positive cells. Error bars show 
the SD from the mean from three independent 
experiments. A minimum of 30 cells with chro-
matin bridges was analyzed per experiment. 
***, P < 0.001 compared with the control. 
Statistically significant differences were deter-
mined by ANO VA and Student’s t test.
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Phosphorylation at S51 promotes Src kinase activity
To investigate Src-S51 phosphorylation, an antiphospho–Src-
S51 antiserum was raised against the human protein sequence. 
This antiserum recognized phosphorylated WT GST-Src (1–256) 
by Chk1 but not the mutant S51A or the unphosphorylated GST-
Src (1–256) protein, showing that this reagent is specific for the 
phosphorylation (Fig.  8  C). Recombinant GST-Chk1 enhanced 
Src-mediated phosphorylation of FAK-Y925 and autophosphory-
lation of Src-Y419, and this coincided with increased phosphory-
lation of Src-S51 by Chk1 in vitro (Figs. 8 D and S4 D). We propose 
that Chk1 phosphorylates Src-S51 and enhances Src catalytic 
activity in vitro.
Furthermore, WT, S51A, or S51D Src-GFP harboring a phos-
phomimetic mutation of S51 to aspartic acid were transfected 
into cells, and GFP-associated kinase activity was determined by 
immunoprecipitation-kinase assays by measuring phosphoryla-
tion of the FAK-Y925 substrate. GFP–Src-S51A exhibited reduced 
catalytic activity by ∼50% compared with the WT GFP-Src or 
GFP–Src-S51D (Fig. 8 E). In comparison, treatment of cells with 
PP2 almost completely inhibited WT Src-GFP kinase activity as 
measured by autophosphorylation of Src-Y419 (Fig. S4 E). In 
addition, immunoprecipitated S51D but not S51A or WT GFP-
Src from Chk1-depleted cells phosphorylated FAK-Y925 to levels 
similar to WT GFP-Src from Chk1-proficient cells, showing that 
GFP–Src-S51D catalytic activity is independent of Chk1 (Fig. 8 F). 
Together, these results show that S51 phosphorylation is required 
for complete Src catalytic activity.
Phosphorylation at S51 enhances Src catalytic activity in the 
absence of Y530 phosphorylation
One possibility is that S51 phosphorylation enhances Src cat-
alytic activity by promoting dephosphorylation of the inhib-
itory site Src-Y530 (Shenoy et al., 1992; Stover et al., 1994). To 
investigate this, we generated a mutant GFP–Src-Y530F protein 
Figure 5. Chk1 or Src depletion exacer-
bates chromatin breakage and reduces actin 
patches in Aurora B–deficient cells. (A) Cells 
were transfected with negative siRNA (control), 
Aurora B siRNA (siAurora B), or a combination 
of siChk1/siSrc and siAurora B (siAurora B + 
siChk1; siAurora B + siSrc). Broken DNA bridges 
and intercellular canals are indicated by dotted 
arrows, midbodies and midbody remnants by 
arrowheads, and the bases of the intercellular 
canals by solid arrows. Relative actin patch 
intensity values are shown. Insets show 1.6× 
magnification of the canals bases. (B) Percent-
age of DNA bridges that appear broken. Error 
bars show the SD from the mean from three 
independent experiments. A minimum of 50 
cells with chromatin bridges was analyzed per 
experiment. (C) Actin patches intensity. Relative 
green fluorescence from A is shown, and values 
in control were set to 1. Error bars show the SD 
from the mean. n = 30 from three independent 
experiments. (D) Frequency of cells with bro-
ken DNA bridges exhibiting intact midbodies. 
Error bars show the SD from the mean from 
three independent experiments. A minimum of 
20 cells with chromatin bridges was analyzed 
per experiment. (E) Localization of Plk1. Insets 
show 1.6× magnification of the midbodies. 
Bars, 5 µm. (F) Plk1 midbody intensity. Relative 
green fluorescence from E is shown, and values 
in telophase control were set to 1. Error bars 
show the SD from the mean. n = 20 cells from 
two independent experiments. ***, P < 0.001 
compared with the control. Statistically signif-
icant differences were determined by ANO VA 
and Student’s t test.
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harboring a nonphosphorylatable mutation of Y530 to phenyl-
alanine (Y530F). GFP–Src-Y530F exhibited increased catalytic 
activity compared with the WT GFP-Src as evidenced by phos-
phorylation of FAK-Y925 substrate by the immunoprecipitated 
GFP proteins in vitro (Fig.  9  A), in agreement with previous 
findings (Piwnica-Worms et al., 1987; Brábek et al., 2002). How-
ever, introducing the S51A mutation into the activated GFP–Src-
Y530F reduced its catalytic activity (Fig. 9 A), showing that S51 
phosphorylation can promote Src catalytic activity in the absence 
of Y530 phosphorylation.
Figure 6. Src localizes to actin patches in cells with chromatin bridges. (A–E) Localization of Src (A), phosphorylated Src-Y419 (pSrc-Y419; B), phos-
phorylated FAK-Y925 (pFAK-Y925; C and D), or cortactin (E). Cells were transfected with negative siRNA (control) or siChk1, or treated with PP2 for 5 h. 
(F) Localization of GFP-Chk1. Broken DNA bridges are indicated by dotted arrows, and the bases of the intercellular canals are indicated by solid arrows. Images 
are representative of 20 cells from two independent experiments. Insets show 1.6× magnification of the canals bases. Bars, 5 µm.
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Chk1 is required for Src-S51 phosphorylation in cultured cells
Confocal microscopy analysis showed that phosphorylated Src-
S51 localized to actin patches in control cells with chromatin 
bridges (Figs. 9 B and S4 F). Depletion of Src by siRNA diminished 
phospho-S51 staining compared with control cells (Fig. 9 B). Fur-
thermore, phospho-S51 staining was impaired after incubation 
of the anti–pSrc-S51 antiserum with the phosphorylated pep-
tide phospho-S51 compared with the unphosphorylated peptide 
S51 synthetic peptides (Fig. S4 F), verifying that this reagent is 
specific for the phosphorylated Src-S51 in immunofluorescence. 
Phosphorylated Src-S51 also localized to membrane ruffles, filo-
podia, and the nucleus and partially colocalized with vinculin at 
focal adhesions in interphase cells on fibronectin, in the absence 
of chromatin bridges (Figs. 9 C and S5, A and B). Depletion of 
Chk1 diminished Src-S51 phosphorylation compared with con-
trol cells in the absence or presence of DNA bridges, showing 
that S51 phosphorylation is Chk1-dependent (Fig. 9, B–D). Chk1 
was precipitated from cell extracts using an antibody against the 
endogenous Src and associated with GST-Src but not with GST 
in pulldown experiments (Figs. 9 E and S5 C). These results sug-
gest that Chk1 associates with Src and phosphorylates Src-S51 in 
interphase cells.
Phosphorylated Src-S51 prevents chromatin breakage
In cells depleted of the endogenous Src by siSrc-2, expression of 
the phosphomimetic mutant S51D but not WT GFP-Src resistant 
to degradation by siSrc-2 prevented chromatin breakage and res-
cued formation of actin patches after Chk1 depletion compared 
with Chk1-proficient controls (Fig. 10, A and C). Furthermore, 
GFP–Src-S51D localized to actin patches in Chk1-deficient or con-
trol cells (Fig. 10 A). In contrast, expression of the nonphosphor-
ylatable mutant Src–GFP-S51A induced chromatin breakage and 
diminished formation of actin patches in the absence or presence 
of siChk1 (Fig. 10, A–D). We propose that Chk1-mediated Src-S51 
phosphorylation is required for actin patch formation and inhi-
bition of chromatin breakage in late cytokinesis. Also, expression 
Figure 7. Chk1-inhibition reduces Src kinase 
activity. (A and B) Cells transfected with neg-
ative siRNA (control) or siChk1 were trypsinized 
and seeded on fibronectin-coated dishes in the 
absence or presence of PP2 for 1 h. Western blot 
analysis of total phospho–Src-Y419 (pSrc-Y419), 
Src, phospho–FAK-Y925 (pFAK-Y925), FAK, or 
actin. NS, nonspecific. Relative band intensity 
values are shown, and values in control were set 
to 1. (C) Chk1 depletion reduces cell spreading. 
Cells were seeded on fibronectin-coated dishes 
and phase-contrast images taken at various 
times after plating. Bars, 50 µm. (D) Percent-
age of spread cells (i.e., flattened and not highly 
reflective) from C. Error bars show the SD from 
the mean from three independent experiments. 
Approximately 750–1,000 cells were analyzed per 
experiment. (E) Cells were seeded on fibronec-
tin-coated dishes and analyzed by wound healing 
assay. Phase-contrast images at 0 h and 12 h after 
wounding are shown. Bars, 200 µm. (F) Wound 
area covered calculated from cells as in E. Error 
bars show the SD from the mean from four inde-
pendent experiments. **, P < 0.01; ***, P < 0.001 
compared with the control. Statistically signifi-
cant differences were determined by ANO VA and 
Student’s t test.
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of S51D GFP-Src increased the number of filopodia in interphase 
cells without DNA bridges compared with cells expressing GFP 
only (Fig. S5, D and E), in agreement with previous studies 
showing that Src catalytic activity promotes filopodia formation 
(Robles et al., 2005; He et al., 2015).
Discussion
Control cells with chromatin bridges delay abscission and retain 
actin patches at the base of the chromatin bridge/intercellular 
canal; however, the molecular mechanisms of actin patch for-
mation have not been previously reported (Chen and Doxsey, 
2009; Steigemann et al., 2009). In this study, we show that Src, a 
nonreceptor tyrosine kinase that is involved in actin remodeling 
(Frame, 2002; Playford and Schaller, 2004), and Chk1, a kinase 
that functions in different stages of the cell cycle (Zhang and 
Hunter, 2014), prevent chromosome breakage and are required 
for formation of actin patches in cytokinesis. Chromatin break-
age in Chk1- or Src-deficient cells is not caused by abscission as 
evidenced by the majority of cells exhibiting broken chromatin 
with an intact intercellular canal and also by the inability of a 
dominant-negative Vps4-K173Q protein that inhibits abscission 
to prevent chromatin bridges from breaking (Morita et al., 2007; 
Petsalaki and Zachos, 2016). Although a potential function for 
Chk1 and Src in DNA breakage that is independent of their role in 
regulating actin patches cannot be formally excluded, our results 
are consistent with Chk1 and Src preventing DNA bridges from 
breaking by promoting formation of actin patches. A minority of 
Chk1- or Src-deficient cells exhibit both fragmented chromatin 
bridges and broken intercellular canals; this could be caused by 
reduced stability of the intercellular canal in the absence of actin 
patches or by weakening of the abscission checkpoint after chro-
matin breakage, perhaps because of released membrane tension 
or the broken chromatin being reeled in from the canal (Lafaurie-
Janvore et al., 2013; Nähse et al., 2017). In addition, Chk1 or Src 
inhibition exacerbates chromatin breakage in Aurora B–deficient 
cells with an impaired abscission checkpoint (Steigemann et al., 
2009), and this correlates with reduced actin patches and with 
Figure 8. Mutation of human Src-S51 to ala-
nine reduces Src catalytic activity. (A) Chk1 
kinase assay. Top: Autoradiography analysis (32P) 
of phosphorylated Src using purified WT or S51A 
GST-Src (1–256) substrate. Bottom: Western blot 
(WB) analysis of total GST. Top and bottom pan-
els are from the same gel. (B) Alignment of Src 
protein sequences. Human serine 51 is marked by 
an asterisk. (C) Chk1 in vitro kinase assay. West-
ern blot analysis of phosphorylated (pSrc-S51) by 
using the anti-pS51 antiserum along with total 
GST-Src. (D) In vitro kinase assay using recom-
binant GST-Chk1, His-Src, and purified GST-FAK 
(871–1020) as substrate. Western blot analysis 
of phosphorylated FAK-Y925 (pFAK-Y925) and 
pSrc-S51 using phosphospecific antibodies, 
and Ponceau staining of GST-FAK (871–1020) 
and His-Src. Relative band intensity values are 
shown, and values in the second lane from left 
(His-Src) were set to 1. (E) Immunoprecipitation 
(IP) kinase assay using GST-FAK (871–1020) as 
substrate. Top: Western blot analysis of GFP-as-
sociated FAK-Y925 phosphorylation and immu-
noprecipitated GFP, and Ponceau staining of GST-
FAK (871–1020). Bottom: Western blot analysis 
of total GFP and actin. Relative band intensity 
values are shown, and values in GFP–Src-WT 
were set to 1. Ab, antibody. (F) Immunoprecip-
itation-kinase assay in the absence or presence 
of siChk1. Top: Western blot analysis of GFP- 
associated FAK-Y925 phosphorylation, immuno-
precipitated GFP, and GST-FAK (871–1020). Bot-
tom: Western blot analysis of total GFP and actin. 
Relative band intensity values are shown, and val-
ues in GFP–Src-WT without siChk1 were set to 1.
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increased frequency of double-deficient cells exhibiting chro-
mosome breakage in the presence of an intact midbody com-
pared with cells depleted of Aurora B only. We propose that actin 
patch formation by Chk1 and Src cooperates with the Aurora B–
imposed abscission delay to prevent chromatin breakage. These 
results also suggest that Chk1 and Src are not essential for the 
abscission delay in response to chromatin bridges. Because Chk1 
is required for abscission delay after replication stress, one pos-
sibility is that replication stress and chromatin trapped at the 
intercellular canal can trigger separate signaling pathways that 
can converge on Aurora B to impose the abscission checkpoint 
(Mackay and Ullman, 2015; Nähse et al., 2017).
We also show that Chk1 is required for optimal localization 
and complete activation of Src, efficient cell spreading, and 
wound healing on fibronectin. Chk1 associates with Src and 
phosphorylates human Src at the conserved serine 51 inside the 
Src-Unique region. Phosphorylated Src-S51 localizes to mem-
brane ruffles, filopodia, and the nucleus. Also, phosphorylated 
Src-S51 and Src-signaling proteins such as phosphorylated FAK-
Y925 and cortactin localize to actin patches in control cells with 
chromatin bridges. Mutation of S51 to a nonphosphorylatable 
alanine residue reduces Src catalytic activity by ∼50% compared 
with the WT protein, diminishes actin patches, and induces chro-
matin breakage. In addition, expression of a phosphomimetic 
Src-S51D protein rescues formation of actin patches and prevents 
chromatin breakage in Chk1-deficient cells.
On the basis of these findings, we propose the following 
model (Fig.  10  E): Chk1 phosphorylates Src at serine 51, and 
Figure 9. Chk1 depletion reduces Src-S51 
phosphorylation. (A) Immunoprecipitation (IP) 
kinase assay using GST-FAK (871–1020) as sub-
strate. Top: Western blot analysis of GFP-asso-
ciated FAK-Y925 phosphorylation (pFAK-Y925) 
and immunoprecipitated GFP as well as Ponceau 
staining of GST-FAK (871–1020). Bottom: West-
ern blot analysis of total GFP and actin. Relative 
band intensity values are shown, and values in 
GFP–Src-WT were set to 1. (B) Localization of 
phosphorylated Src-S51 (pSrc-S51). Cells were 
transfected with negative siRNA (control), siChk1, 
or siSrc. Broken DNA bridges are indicated by 
dotted arrows, and the bases of the intercellular 
canals are indicated by solid arrows. Insets show 
1.6× magnification of the canals bases. Images are 
representative of 20 cells from two independent 
experiments. (C) Cells transfected as in B were 
seeded on fibronectin-coated slides for 1 h. Insets 
show 2× magnification of membrane ruffles. Bars, 
5 µm. (D) Phosphorylated Src-S51 at membrane 
ruffles. Relative green fluorescence intensity 
from C is shown, and values in control were set 
to 1. Error bars show the SD from the mean. 
n = 20 cells from two independent experiments. 
***, P < 0.001 compared with the control. Statis-
tically significant differences were determined by 
ANO VA and Student’s t test. (E) Coimmunopre-
cipitation from asynchronous cells. Chk1 or Src 
were detected by Western blotting. Ab, antibody.
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this phosphorylation is required for optimal Src localization, 
complete Src kinase activity, and efficient cell migration and 
spreading. Furthermore, in the presence of chromatin bridges, 
phosphorylated Src-S51 and Src-signaling proteins promote 
formation of actin patches and prevent chromosome breakage 
in cytokinesis.
Phosphorylation of serine 51 can promote Src kinase activity 
independently of Src-Y530 phosphorylation. Structurally, the 
Y530F mutant of Src remains 85% in its inactive closed form, and 
the SH3 domain of Src can down-regulate Src kinase activity in 
the absence of Y530 phosphorylation through interactions with 
the kinase N-terminal lobe (Xu et al., 1999; Brábek et al., 2002; 
Bernadó et al., 2008). The Src-SH3 domain also interacts with the 
Unique domain through a binding region in the opposite side of 
the SH3 peptide binding site, and the SH3–Unique domain inter-
action is lost after addition of a high-affinity SH3 ligand peptide 
that induces the active open conformation of the kinase (Maffei 
et al., 2015). Therefore, one possibility is that S51 phosphoryla-
tion activates Src by destabilizing the interaction between the 
SH3 and the Unique domain to promote the open conformation. 
In addition, because S51 is inside the unique domain lipid binding 
region, S51 phosphorylation may modulate interactions between 
the Unique domain and lipids to regulate Src localization (Pérez 
et al., 2013; Amata et al., 2014).
How do actin patches stabilize chromatin bridges? The oval 
or heart shape of many of the nuclei in telophase cells with 
chromatin bridges suggests that considerable pulling forces are 
exerted by the chromosomes in the bridge. These forces could 
cause chromatin breakage by mechanical rupture or induce 
transient nuclear envelope rupture during interphase, followed 
by bridge resolution by nuclease activity (Ganem and Pellman, 
2012; Maciejowski et al., 2015). Perhaps, intriguingly, breakage 
of chromatin bridges in cells proficient for the abscission check-
point preferentially occurs next to centromeres at the foot of the 
Figure 10. Expression of the phosphomimetic 
Src-S51D mutant rescues formation of actin 
patches and prevents chromatin breakage in 
Chk1-deficient cells. (A and B) Cells expressing 
WT, S51D, or S51A GFP-Src resistant to degrada-
tion by siSrc-2 were depleted of the endogenous 
Src by siSrc-2 and transfected with negative 
siRNA (control) or siChk1. Broken DNA bridges 
are indicated by dotted arrows, and the bases 
of the intercellular canals are indicated by solid 
arrows. Relative actin patch intensity values are 
shown. Insets show 1.6× magnification of the 
canals bases. Bars, 5 µm. (C) Percentage of DNA 
bridges that appear broken in GFP-positive cells. 
Error bars show the SD from the mean from three 
independent experiments. A minimum of 30 cells 
with chromatin bridges was analyzed per exper-
iment. (D) Actin patches intensity. Relative red 
fluorescence from A and B is shown, and values 
in GFP–Src-WT control were set to 1. Error bars 
show the SD from the mean. n = 30 cells from 
three independent experiments. ***, P < 0.001 
compared with the control. Statistically signifi-
cant differences were determined by ANO VA and 
Student’s t test. (E) Model for the role of Chk1 
and Src in cytokinesis with chromatin bridges. 
p, phosphorylation.
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DNA bridge, around where actin patches are formed, indicating 
this chromatin region is under relatively high tension (Hoffelder 
et al., 2004; Petsalaki et al., 2014; Lopez et al., 2015). One possi-
bility is that the dense meshwork of highly organized actin fila-
ments inside the actin patches provides mechanical support to 
the nuclear envelope and underlying chromatin by increasing 
the stiffness and elasticity at the base of the chromatin bridge 
to counteract the pulling forces applied by the chromosomes 
in the bridge. Because cross-linkers affect the architecture and 
mechanical properties of the actin network, identifying how 
actin filaments are organized and linked together inside the 
patches may help us understand how such forces are acting 
(Fletcher and Mullins, 2010).
Phosphorylated FAK-Y925 and cortactin were also detected 
at actin patches. Focal adhesion proteins are involved in mecha-
notransduction and can promote force-dependent actin polym-
erization (Geiger et al., 2009; Houk et al., 2012). Investigating 
which Src-signaling proteins are required for actin patch forma-
tion in response to DNA bridges may help us better understand 
how cells stabilize chromatin bridges. In conclusion, our study 
identifies novel proteins that promote formation of actin patches 
and protect against chromatin breakage in cytokinesis.
Materials and methods
Antibodies
Anti-pS51 polyclonal antiserum was generated in rabbits by 
immunization against the phosphorylated peptide phospho-S51 
(DGH RGP[pSER]AAF APA AC) of human Src (Genscript). The 
unphosphorylated peptide S51 (DGH RGP SAA FAP AAC) was used 
in competition experiments as appropriate.
Mouse monoclonal antibodies against GST (B-14), Chk1 
(G-4), FAK (D-1), cortactin (H-5), vinculin (7F9), and Cep55 (B-8; 
sc-374051) were from Santa Cruz Biotechnology. Rabbit poly-
clonal antibodies against GFP (full length; sc-8334), c-Src (N-16; 
sc-19 used in immunofluorescence), Plk1 (H-152; sc-5585), and 
Mklp1 (N-19; sc-867) were also from Santa Cruz Biotechnology. 
Rabbit polyclonal antibodies against Aurora B (ab2254) and Src 
(ab109381, used in Western blotting) were from Abcam, rabbit 
polyclonal antibody against phospho–Src-Y419 (Src [pY418], 
44660G) was from Invitrogen, and mouse monoclonal antiphos-
pho–histone H2A.X (S139; clone JBW301; γ-H2AX) was from 
EMD Millipore (05-636). Mouse monoclonal antibodies against 
α-tubulin (DM1A) and actin (AC-40) were from Sigma-Aldrich, 
mouse monoclonal anti–lamin B2 (E-3) was from Thermo Fisher 
Scientific (33-2100), and rabbit polyclonal antibody against 
phospho–FAK-Y925 (AF44671) was from R&D Systems.
Plasmids and cloning
Plasmid pEGFP/c-Src encoding WT human c-Src (1–536 with 
1 designating the initiator methionine) fused to EGFP into 
pcDNA4/TO vector (Invitrogen) was a gift from N. Yamagushi 
(Chiba University, Chiba, Japan; Kasahara et al., 2007b). Plas-
mid pEGFP/av c-Src encoding the full length chicken c-Src fused 
to EGFP into pEGFP-N1 vector (Takara Bio Inc.) was from M. 
Resh (Memorial Sloan-Kettering Cancer Center, New York, NY; 
Donepudi and Resh, 2008), and plasmid pEGFP/FAK encoding 
full-length human FAK N-terminally fused to GFP into pCS105 
(Addgene) was from P. Skourides (University of Cyprus, Nico-
sia, Cyprus). Plasmid pEGFP-vps4-K173Q encoding human VPS4 
harboring the K173Q point mutation fused to EGFP into pEGFP-C1 
vector (Takara Bio Inc.) was a gift from W. Sundquist (Univer-
sity of Utah, Salt Lake City, UT; Morita et al., 2007), and plasmid 
pEGFP-N1 coding for GFP under cytomegalovirus promoter was 
obtained from Takara Bio Inc.
Plasmid pEGFP/Chk1 encoding human Chk1 fused to EGFP 
into pEGFP-N1 vector (Takara Bio Inc.) was from Addgene 
(22888; Unsal-Kaçmaz et al., 2005). Sequencing of this plasmid 
showed that Chk1 exhibited mutation of aspartic acid-130 to ala-
nine (D130A), and this mutation was reversed to obtain the WT 
pEGFP/Chk1 plasmid.
To generate the pGEX4T1/av c-Src vector encoding GST-
tagged avSrc, a full-length avian c-Src cDNA sequence was 
amplified by PCR by using pEGFP/av c-Src as template and cloned 
into the pGEX4T1 vector (GE Healthcare) as a BamHI-EcoRI frag-
ment. To generate pGEX4T1/c-Src or pGEX4T1/c-Src (1–256) 
vectors encoding GST-tagged full-length or truncated human 
Src, a human c-Src cDNA sequence was amplified by PCR using 
pEGFP/c-Src as template and cloned into the pGEX4T1 vector 
with EcoRI-XhoI. To generate pGEX4T1/FAK (871–1020) encoding 
a GST-tagged truncated form of human FAK, FAK cDNA sequence 
was amplified by PCR using pEGFP/FAK as a template and cloned 
into the pGEX4T1 vector with BamHI-XhoI. All plasmids were 
completely sequenced.
siRNA sequences
Negative siRNAs (a pool of four different siRNAs: 5′-UAA GGC 
UAU GAA GAG AUAC-3′, 5′-AUG UAU UGG CCU GUA UUAG-3′, 
5′-AUG AAC GUG AAU UGC UCAA-3′, and 5′-UGG UUU ACA UGU CGA 
CUAA-3′) were from Thermo Fisher Scientific/GE Healthcare. 
Human Chk1 (a pool of four different siRNAs: 5′-CAA GAU GUG 
UGG UAC UUUA-3′, 5′-GAG AAG GCA AUA UCC AAUA-3′, 5′-CCA CAU 
GUC CUG AUC AUAU-3′, and 5′-GAA GUU GGG CUA UCA AUGG-3′), 
Chk1-2 (5′-CCA CAU GUC CUG AUC AUAU-3′), Src-2 (5′-GCA GUU 
GUA UGC UGU GGUU-3′), and Aurora B (5′-CCA AAC UGC UCA GGC 
AUAA-3′) siRNAs were also from Thermo Fisher Scientific/GE 
Healthcare. Human Src (a pool of four different siRNAs: 5′-CUC 
GGC UCA UUG AAG ACAA-3′, 5′-UGA CUG AGC UCA CCA CAAA-3′, 
5′-CCU CAU CAU AGC AAU AACA-3′, and 5′-GUA GAU UUC AGA UGA 
CUAU-3′) siRNAs were obtained from Santa Cruz Biotechnology. 
Only the sense sequences of the siRNA duplexes are shown.
Mutagenesis
Point mutations were generated by using the Q5 site-directed 
mutagenesis kit (New England Biolabs). To generate siRNA- 
resistant forms of GFP-Src, the pEGFP/c-Src coding for human 
GFP-Src was used to introduce T982C, G984A, and T987C point 
mutations giving resistance to the Src-2 siRNA. This plasmid was 
then used to make A151G and G152C point mutations changing 
Src-S51 to alanine or A151G and G152A point mutations changing 
Src-S51 to aspartic acid. For changing Src-Y530 to phenylalanine, 
the pEGFP/c-Src plasmid was used to make the A1589T point 
mutation. To revert the D130A mutation on human GFP-Chk1, the 
pEGFP/Chk1 plasmid from Addgene (22888) was used to make a 
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C389A point mutation changing the Chk1-A130 to aspartic acid 
and generate the WT GFP-Chk1 protein. To generate siRNA-resis-
tant forms of GFP-Chk1, the WT pEGFP/Chk1 plasmid was used to 
introduce A1044C, T1047C, and T1050A point mutations giving 
resistance to the Chk1-2 siRNA.
Recombinant and purified proteins
Recombinant human GST-Chk1 (14-346) and His-Src (14-326) 
were from EMD Millipore. GST-tagged proteins were expressed 
in BL21 (DE3) cells (Agilent Technologies) and purified by using 
glutathione-agarose beads (Santa Cruz Biotechnology) or were 
eluted from beads by using the GST spintrap purification module 
(GE Healthcare).
Cell culture and treatments
Human colon carcinoma BE cells (a gift from S. Wilkinson 
and C. Marshall, Institute of  Cancer Research, London, UK; 
Petsalaki et al., 2018) and cervical carcinoma HeLa cells stably 
expressing LAP2b fused to RFP (a gift from D. Gerlich, Insti-
tute of Molecular Biotechnology, Vienna, Austria; Steigemann 
et al., 2009) were grown in DMEM (Gibco) containing 10% FBS 
at 37°C in 5% CO2. Cells were treated with 300 nM UCN-01 
(U6508; Sigma-Aldrich), 10 µM PP2 (1407; Tocris Bioscience), 
or 1 µM TG003 (T5575; Sigma-Aldrich) as appropriate. Neg-
ative siRNA or siRNA duplexes designed to repress human 
Chk1, Src, or Aurora B were transfected into BE cells 24  h 
before analysis using Lipofectamine 2000 (Invitrogen). For 
expression of GFP proteins, plasmids were transfected into 
cells in the absence or presence of appropriate siRNA duplexes 
24 h before analysis or further drug treatment using Turbofect 
(Thermo Fisher Scientific). All cell lines used exhibited con-
sistent morphology and growth properties and were negative 
for mycoplasma contamination.
Coating with fibronectin
Petri dishes or slides were incubated with 1 µg/ml fibronectin 
(EMD Millipore) for 1 h at 37°C before use.
Time-lapse imaging
BE or HeLa LAP2b-RFP cells were seeded onto Petri dishes with 
a 30-mm glass base (Greiner), and an inverted fluorescence 
microscope (Observer D1; Zeiss) was used. Fluorescence and 
phase-contrast images were taken by using a 63× Plan Neofluor 
0.75 NA Ph2 dry objective (Zeiss; Figs. 1 E and S1 C), a 20× Plan 
Neofluor 0.40 NA Ph2 dry objective (Zeiss; Fig. 7, C and D), or a 
10× A-plan 0.25 Ph1 dry objective (Zeiss; Fig. 7, E and F). Imaging 
was performed at 37°C in 5% CO2 by using a Zeiss AxioCam MRm 
camera and the Zeiss ZEN 2 acquisition software. For UCN-01 
or PP2 treatments in Figs. 1 and 7, the drugs were added to the 
medium immediately before filming.
Cell spreading assay
Confluent cells were trypsinized and counted, and 1 × 106 BE 
cells were plated on fibronectin-coated 35-mm dishes. Cells were 
photographed every 20 min at 37°C in 5% CO2 by using a Zeiss 
AxioCam MRm camera (see the Time-lapse imaging section), 
and the percentage of spread cells (i.e., cells that were flattened 
and relatively less reflective) was calculated at various times. The 
method was adapted from Brunton et al. (2005).
Wound healing assay
Fibronectin-coated 35-mm dishes containing a confluent mono-
layer of cells were used, and a wound was created by scraping 
the monolayer with a yellow gel loading tip. The dish was sub-
sequently washed with warm PBS and the wound area photo-
graphed at desired time points (0–16 h) at 37°C in 5% CO2 by using 
an AxioCam MRm camera. The wound area without cells was 
measured using a region/polygon tool (ZEN 2 software), and the 
percentage of wound area recovered (wound closure) was calcu-
lated. The method was adapted from Elias et al. (2010).
Indirect immunofluorescence microscopy
For intercellular canal labeling with FM 1-43FX, see Intercellular 
canal labeling. For all other fluorescence microscopy applica-
tions, cells were fixed in 4% paraformaldehyde in cytoskeleton 
buffer (1.1 M Na2HPO4, 0.4 M KH2PO4, 137 mM NaCl, 5 mM KCl, 
2 mM MgCl2, 2 mM EGTA, 5 mM Pipes, and 5 mM glucose, pH 6.1) 
for 5 min at 37°C, permeabilized in 0.5% Triton X-100 in cytoskel-
eton buffer, washed twice with PBS at room temperature, and 
immunostained. For peptide competitions, 2.2 µg of the anti-pS51 
polyclonal antiserum was incubated with 100 µg peptide at 37°C 
for 1 h, and then used for immunostaining.
FITC- or rhodamine-TRI TC-conjugated secondary antibod-
ies (Jackson ImmunoResearch Laboratories, Inc.) were used 
as appropriate. DNA was stained with 10 µM TO-PRO-3 iodide 
(642/661 nm; Invitrogen), and cells were mounted in Vectashield 
medium (Vector Laboratories). Images were collected by using 
a laser-scanning spectral confocal microscope (TCS SP2; Leica 
Microsystems), LCS Lite software (Leica Microsystems), and 
a 63× Apochromat 1.40 NA oil objective. The low-fluorescence 
immersion oil (11513859; Leica) was used, and imaging was per-
formed at room temperature. Mean projections of image stacks 
were obtained by using the LCS Lite software.
Intercellular canal labeling
Cells were incubated with 5 µg/ml FM 1-43FX fluorescence dye 
(F35355; Thermo Fisher Scientific/Invitrogen) in ice-cold Opti-
MEM medium (11058021; Thermo Fisher Scientific) for 5 min at 
4°C. The dye was then removed, and the cells were fixed with 
ice-cold 4% paraformaldehyde in cytoskeleton buffer for 10 min 
at 4°C. Next, the cells were permeabilized with 0.5% Triton X-100 
in warm (37°C) cytoskeleton buffer for 5 min at room tempera-
ture, washed three times with warm (37°C) PBS, and stained with 
10 µM TO-PRO-3 iodide (Invitrogen).
Quantification of fluorescence signals
Fluorescence intensity signals at midbodies were quantified 
using the LCS Lite ellipse tool by analyzing an image area of 2 µm2 
around each midbody, and intensity values were normalized ver-
sus values obtained by analyzing an identical area within the cell 
immediately adjacent on the midbody (Waters, 2009; Petsalaki 
and Zachos, 2016).
Actin patch-fluorescence intensity signals were quantified 
using the LCS Lite polygon tool by analyzing an image area of 
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40 µm2 around the base of the DNA bridge, and intensity val-
ues were normalized versus values obtained by analyzing an 
identical area within the cell near the base of the DNA bridge 
(Waters, 2009).
DNA bridge-fluorescence intensity signals were quantified 
using the LCS Lite polygon tool by analyzing an image area 
encompassing the entire DNA bridge or intercellular canal, and 
intensity values were normalized versus values obtained by ana-
lyzing an identical area outside the canal. For weak versus strong 
DNA staining, DNA bridge-fluorescence intensity signals from 
40 control bridges were quantified, and the mean value was set to 
0.5. DNA bridges exhibiting relative fluorescence intensity >0.5 
were taken as strong, whereas those exhibiting relative fluores-
cence intensity <0.5 were classified weak DNA signals.
Fluorescence intensity signals at membrane ruffles were 
quantified using the LCS Lite polygon tool by analyzing an image 
area of 100 µm2 around the membrane, and intensity values 
were normalized versus values obtained by analyzing an identi-
cal area within the cell immediately adjacent on the membrane 
(Waters, 2009).
Mass spectrometry
GST–avSrc bands were excised from the gel and digested with 
trypsin, and the extracted tryptic peptides were analyzed by 
liquid chromatography–mass spectrometry as described previ-
ously (Ducommun et al., 2015). The data were searched against 
an in-house database containing the avian c-Src sequence using 
Mascot (2.4.1; Matrix Science) and MaxQuant (1.3.8.2). All result 
files were loaded into Scaffold (4.8.4; Proteome Software Inc.). 
Protein thresholds were set to 95.0% with a two unique peptide 
threshold to report protein identification. Peptide identifications 
were accepted if they could be established at >95.0% probability 
as specified by the Peptide Prophet algorithm (Keller et al., 2002), 
resulting in a peptide false discovery rate of 0.76%.
In vitro kinase assays
For the in vitro Chk1 kinase assays in Figs. 8 A and S4 A, 0.5 µg 
recombinant GST-Chk1 was incubated with 1 µg GST-Src pro-
tein substrate in 20 µl Chk1 kinase buffer (20 mM MOPS, pH 7.2, 
5 mM EGTA, 10 mM MgCl2, 25 mM sodium β-glycerophosphate, 
1 mM sodium vanadate, 1 mM DTT, 100 µM ATP, and 1 µCi γ-32P 
ATP) for 20 min at 30°C before analysis by SDS-PAGE. Radioac-
tive labeling of Chk1 substrates was determined by autoradiogra-
phy. The in vitro Chk1 kinase assay in Fig. 8 C was as above except 
that the γ-32P ATP was omitted from the reaction mixture, and 
phosphorylation of Chk1 substrates was determined by Western 
blotting using an antiserum against phospho–Src-S51.
For the in vitro kinase assays in Figs. 8 D and S4 (C and D), 0.5 
µg recombinant GST-Chk1 and 0.5 µg recombinant His-Src were 
incubated with 1 µg GST-FAK (871-1020) protein substrate eluted 
from beads in 20 µl Src kinase buffer (40 mM MOPS, 1 mM EDTA, 
and 0.1 mM ATP) for 30 min at 30°C before analysis by SDS-PAGE. 
Labeling of the GST-FAK (871–1020) substrate was determined by 
Western blotting using an antibody against phospho–FAK-Y925, 
and Src-S51 phosphorylation was determined by Western blotting 
using an antiserum against phospho–Src-S51. Where appropriate, 
145 ng UCN-01 or 3 µg PP2 were included in the kinase reaction.
GFP immunoprecipitation and kinase assay
For GFP immunoprecipitations (Fig. 8, E and F), cells were son-
icated three times for 10  s in ice-cold immunoprecipitation/
kinase buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM EDTA, 
2.5 mM EGTA, 10% glycerol, 0.1% Tween 20, 0.1 mM PMSF, 10 µg/
ml leupeptin, 10 µg/ml aprotinin, 1 mM sodium fluoride, 10 mM 
sodium β-glycerophosphate, and 0.1 mM sodium vanadate) and 
incubated for another 30 min on ice. 1 mg cell lysate was incu-
bated with 0.5 µg anti-GFP antibody for 16 h followed by the addi-
tion of 10 µl protein A/G PLUS–agarose beads (Santa Cruz Bio-
technology) for 1 h at 4°C. Samples were spun down and washed 
three times with immunoprecipitation/kinase buffer and three 
times with Src reaction buffer (40 mM MOPS and 1 mM EDTA). 
Immunoprecipitated proteins on agarose beads were included 
in a 20-µl reaction in Src reaction buffer containing 1 µg GST-
FAK (871–1020) eluted from beads and 0.1 mM ATP for 30 min 
at 30°C before analysis by SDS-PAGE. Labeling of the GST-FAK 
(871–1020) substrate was determined by Western blotting using 
an antibody against phospho–FAK-Y925.
Protein coimmunoprecipitations and GST-pulldown assays
Cells were lysed as described in the previous section. For coim-
munoprecipitations, 1 mg cell lysate was incubated with 1 µg 
antibody for 16 h followed by the addition of 10 µl protein A/G 
PLUS–agarose beads for 1 h at 4°C. For GST pulldowns, 1 mg cell 
lysate was incubated with 1 µg GST-protein on glutathione-aga-
rose beads for 4 h at 4°C. Samples were spun down and washed 
three times with immunoprecipitation/kinase buffer, and immu-
noprecipitated proteins on agarose beads were analyzed by SDS-
PAGE and Western blotting.
Western blotting
Cells were lysed in ice-cold, whole-cell extract buffer (20 mM 
Hepes, 5 mM EDTA, 10 mM EGTA, 0.4 M KCl, 0.4% Triton X-100, 
10% glycerol, 5 mM NaF, 1 mM DTT, 5 µg/ml leupeptin, 50 µg/ml 
PMSF, 1 mM benzamidine, 5 µg/ml aprotinin, and 1 mM Na3VO4) 
for 30 min on ice. Lysates were cleared by centrifugation at 
15,000 g for 10 min, analyzed by SDS-PAGE, and transferred onto 
nitrocellulose membrane (Santa Cruz Biotechnology).
Densitometry
Densitometric analysis of bands was performed using ImageJ 
(National Institutes of Health).
Statistical analysis
For broken DNA bridges indices, 50 cells per experiment from 
three independent experiments were scored blindly, and the SD 
was calculated (n = 150). For broken DNA bridges indices in cells 
transfected with GFP-proteins, 30 GFP-positive cells per experi-
ment from three independent experiments were scored blindly, 
and the SD was calculated (n = 90). For actin patches fluorescence 
in Figs. 2 E, 3 F, 5 C, and 10 D, 30 cells from three independent 
experiments were examined (n = 30), and the SD was calculated. 
For actin patches fluorescence in Figs. 3 B and S1 G, 20 cells from 
three or two independent experiments, respectively, were exam-
ined (n = 20), and the SD was calculated. For intact intercellular 
canals indices in Fig. 4 B, 15 cells with broken DNA bridges per 
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experiment from three independent experiments were examined 
(n = 45), and the SD was calculated. For intact midbodies indices in 
Fig. 5 D, at least 20 cells per experiment from three independent 
experiments were examined (n > 60), and the SD was calculated. 
For Plk1-, Cep55-, and Mklp1-associated fluorescence, 10 cells per 
experiment from two independent experiments were examined (n 
= 20), and the SD was calculated. For γ-H2AX micronuclei, a min-
imum of 150 cells per experiment from three independent exper-
iments were examined (n > 450), and the SD was calculated. For 
cell spreading assays, ∼750–1,000 cells from five randomly chosen 
fields per experiment from three independent experiments were 
examined, and the SD was calculated (n > 2,100). For wound heal-
ing, one field per experiment from four independent experiments 
was examined (n = 4), and the SD was calculated. For phosphor-
ylated Src-Y419, FAK-Y925, and Src-S51 fluorescence, cell mem-
brane areas from 20 cells from two independent experiments (n 
= 20) were analyzed per treatment, and the SD was calculated. 
For filopodia formation (Fig. S5 E), the number of filopodia per 
cell from 15 cells from two independent experiments (n = 15) was 
determined, and the SD was calculated. Statistically significant 
differences between three or more groups were determined by 
one-way ANO VA followed by Student’s t test between two groups. 
No statistical method was used to predetermine the sample size.
Online supplemental material
Fig. S1 shows the fluorescence intensity of actin patches in 
control, Chk1-deficient, or Src-deficient cells with intact DNA 
bridges. Fig. S1 also shows an example of control cells with a 
broken chromatin bridge, and Src-depleted cells with relatively 
strong or weak DNA bridge staining. Fig. S2 shows localization 
of Mklp1 and Cep55 to the midbody in control, Chk1-deficient, 
or Src-deficient cells in telophase or late cytokinesis. Fig. S3 
shows localization of phosphorylated Src-Y419, phosphorylated 
FAK-Y925, and total Src at membrane ruffles in control, Chk1-de-
ficient, or Src-deficient cells. Fig. S4 shows phosphorylation of 
avian GST-Src by recombinant Chk1 at newly identified sites in 
vitro. Fig. S4 also shows phosphorylations of Src-S51 and Src-
Y419 in vitro in the presence of purified Chk1 and Src proteins, 
and specificity of the antiphospho-S51 antiserum in immunoflu-
orescence. Fig. S5 shows localization of phosphorylated Src-S51 
at focal adhesions and filopodia in interphase cells without chro-
matin bridges. Fig. S5 also shows Chk1 interaction with Src in 
GST pulldown experiments from cell extracts, and the number of 
filopodia per cell in cells expressing S51D GFP-Src. Video 1 shows 
a control HeLa LAP2b-RFP cell exhibiting a stable LAP2b inter-
cellular bridge in cytokinesis. Video 2 shows a HeLa LAP2b-RFP 
cell exhibiting breakage of the LAP2b intercellular bridge in the 
presence of the Src family inhibitor PP2. Video 3 shows a HeLa 
LAP2b-RFP cell exhibiting breakage of the LAP2b intercellular 
bridge in the presence of the selective Chk1 inhibitor UCN-01.
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